NFL legend Joe Montana lived around top VC execs as a 49er, then leveraged those ties to launch his second career as an investor

Joe Montana transitioned from a $15 million fund-of-funds into active early-stage investing after partnering with Ron Conway and founding Liquid 2 in 2015; Liquid 2 has now invested in over 800 companies and was an early backer of GitLab, Rappi, Anduril and Pipe. Montana emphasizes founder quality over product at early stages and leverages his brand and network to access top syndicates, while shifting away from passive fund-of-funds allocations into deeper operational engagement with portfolio companies.

Analysis

Market structure: Celebrity-led angel/seed syndicates (Liquid 2, SV Angel) are winners — they lower information/transaction costs and widen access to top-tier early rounds, likely pushing seed valuations up 10–30% vs. last-cycle norms and compressing expected multiple capture for later-stage LBO/PE funds. Direct public beneficiaries are venture-backed software names with strong brand halo (e.g., GTLB) that can see short-term re-rating; losers are crowded late-stage funds and secondary buyers who now face pricier deal flow and thinner pickings. Cross-asset: limited direct FX/commodity impact, but equity flows from fixed income could rise if HNW/retail rotates from cash into VC-themed public names, nudging equity risk premia modestly tighter.

Risk assessment: Tail risks include regulatory action against fintech (Pipe-like models) or export/security controls hitting defense startups (Anduril analogs), reputational/legal risk from celebrity backers, and a prolonged IPO/exit drought that converts inflated seed valuations into permanent markdowns. Immediate (days) effect is a sentiment bump; short-term (3–12 months) is valuation inflation and increased competition for deal allocations; long-term (2–7 years) outcome hinges on exit environment. Hidden dependency: performance is highly correlated to a small network of top-tier VCs and demo-day cadence — saturation reduces edge quickly. Key catalysts: IPO window reopening, demo days, and Fed rate direction.

Trade implications: Direct play – establish a tactical 1–2% long position in GTLB (GitLab) via a 6–9 month 1:1 call spread to cap cost; target +30–50% if next two quarters give ARR growth >8% QoQ, stop-loss -18%. Proxy defense exposure: add 2–3% to ITA (iShares U.S. Aerospace & Defense) for 6–12 months to capture spillover interest in defense tech startups. Capital reallocation: trim 1–2% from highest-valuation, low-FCF SaaS small-caps and redeploy into private-secondaries or listed proxies; avoid large outright allocations to new celebrity-led funds until they show track record vs. benchmarks.

Contrarian angles: Consensus assumes celebrity cachet guarantees deal access and outperformance — history (late-’90s celebrity pipes into tech, 2015–18 SPAC era) shows deal-flow access can create crowded, low-quality allocations and larger-than-expected write-downs. The market may be underpricing correlation risk: multiple celebrity-backed startups could fail together in a credit/off-ramp event, creating concentrated markdowns; hence cap exposure and prefer option-limited structures. A prudent alternative: participate via capped-cost option structures or buy ETFs/ETFs proxies rather than direct seed exposure until a 3–5 year track record emerges.

Key Decisions for Investors

• Establish a tactical 1–2% long position in GTLB (GitLab) using a 6–9 month call spread (buy ATM call, sell ~20–30% OTM) to limit downside; target +30–50% in 6–12 months if ARR growth >8% QoQ for two consecutive quarters; cut to flat if price drops 18% from entry.
• Add 2–3% exposure to ITA (iShares U.S. Aerospace & Defense ETF) as a public proxy for private defense-tech investor enthusiasm; hold 6–12 months and trim if ITA outperforms S&P by >8% in 30 days or if defense-related regulatory headwinds emerge.
• Trim 1–2% exposure to high-valuation, low-free-cash-flow SaaS small-caps (redeploy into capped-cost option structures or VC-secondary vehicles); specifically shift proceeds into private-secondary allocations or public proxies rather than direct seed rounds until 3–5 year performance data for celebrity funds materializes.
• Avoid large direct commitments to newly advertised celebrity-led funds for 12–24 months; require demonstrated IRR >15% net and at least one realized exit before allocating >3% of risk budget to any single such fund.